Toyama Maya, Satoh Michihiro, Hashimoto Hideaki, Iwabe Yutaro, Yagihashi Takahito, Nakayama Shingo, Murakami Takahisa, Nakaya Naoki, Metoki Hirohito, Hozawa Atsushi, Tabuchi Takahiro
Department of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Division of Public Health, Hygiene and Epidemiology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Hypertens Res. 2025 Feb;48(2):786-795. doi: 10.1038/s41440-024-02067-x. Epub 2025 Jan 8.
Previous studies have shown an increase in blood pressure during the coronavirus disease 2019 (COVID-19) pandemic even among patients receiving antihypertensive treatment. This study aims to evaluate the association between equivalized annual household income and refraining from regular medical visits for hypertensive patients since the COVID-19 outbreak. We analyzed data from the Japan COVID-19 and Society Internet Survey (JACSIS), including 2832 hypertensive patients aged 20-79 years from the 2020 survey and at least one survey between 2021 and 2023. They were categorized into lower-income (<median of ¥3,182,000) and higher-income (≥median) groups. Refraining from regular medical visits was defined as not attending scheduled medical visits for hypertension in the past two months. Poisson regression or generalized linear mixed models were used, inverse probability weighted for Internet survey selection. After weighting, the mean age was 64.8 ± 10.3 years and 63.7% were men. In 2020, the proportion of hypertensive patients refraining from regular medical visits after weighting was 19.6% in the lower-income group and 8.8% in the higher-income group, with an adjusted proportion ratio (95% confidence interval) of 1.86 (1.13-3.06) for the lower-income group compared with the higher-income group. After 2020, the proportion of those refraining from regular medical visits declined in all income groups, and the income-related differences disappeared. During the social restrictions due to the COVID-19 pandemic, hypertensive patients with lower equivalized annual household incomes were more likely to refrain from regular medical visits. Strategies to reduce income-related inequities in medical care utilization may be necessary for future public health crises. A nationwide Internet survey in Japan revealed hypertensive patients with lower equivalized annual household incomes were significantly more likely to refrain from regular medical visits in 2020, during the social restrictions due to the COVID-19 pandemic. Addressing income-related inequities in medical care utilization is crucial for future public health crises.
以往研究表明,在2019冠状病毒病(COVID-19)大流行期间,即便在接受抗高血压治疗的患者中血压也有所升高。本研究旨在评估自COVID-19疫情爆发以来,高血压患者的家庭等效年收入与不进行定期医疗就诊之间的关联。我们分析了日本COVID-19与社会互联网调查(JACSIS)的数据,包括2020年调查中的2832名年龄在20 - 79岁的高血压患者,以及2021年至2023年期间的至少一次调查。他们被分为低收入组(家庭年收入<318.2万日元中位数)和高收入组(家庭年收入≥中位数)。不进行定期医疗就诊被定义为在过去两个月内未参加高血压的定期医疗就诊。使用泊松回归或广义线性混合模型,并对互联网调查选择进行逆概率加权。加权后,平均年龄为64.8±10.3岁,男性占63.7%。2020年,加权后不进行定期医疗就诊的高血压患者比例在低收入组为19.6%,在高收入组为8.8%,低收入组与高收入组相比调整后的比例比(95%置信区间)为1.86(1.13 - 3.06)。2020年之后,所有收入组中不进行定期医疗就诊的比例均下降,与收入相关的差异消失。在COVID-19大流行导致的社会限制期间,家庭等效年收入较低的高血压患者更有可能不进行定期医疗就诊。未来应对公共卫生危机可能需要采取策略来减少医疗服务利用方面与收入相关的不平等。日本的一项全国性互联网调查显示,在2020年COVID-19大流行导致的社会限制期间,家庭等效年收入较低的高血压患者明显更有可能不进行定期医疗就诊。解决医疗服务利用方面与收入相关的不平等对于未来的公共卫生危机至关重要。